You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
Fourteen months ago, the Trump administration clamped down on federally funded fetal tissue research by requiring that such projects go through an ethics review by a new advisory board. On 31 July, that new board's composition was revealed as it met online to review a crop of project proposals. A Science analysis finds that at least 10 of the 15 board members have spoken publicly against abortion, fetal tissue research, or both. Although one prominent bioethicist slammed the board as "stacked" against fetal tissue research, a spokesperson for an antiabortion group described its makeup as "properly balanced." The board's recommendations on the projects must be reported to two congressional committees and to Health and Human Services Secretary Alex Azar by 18 August. Azar will have the final word.
